Permanent activation of the HIF-1 pathway and some other signaling pathways in cancer cells enhance the expression of genes encoding proteins involved not only in tumoral angiogenesis and substrate supply (for instance, erythropoietin and VEGF) (see Figure 2(a)) but also in the glycolytic phenotype (Figure 3). The gene discussed is HIF1A; the disease is cancer.